Sold as Anthelios 20, Anthelios 40. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 2 applications for Avobenzone; Ecamsule; Octocrylene; Titanium Dioxide (sold as Anthelios 20, Anthelios 40), first approved Oct 5, 2006, with 1 new use approved and 0 published complete response letters.
| Oct 5, 2006 | Anthelios 20NDA 21471 · New combination | Loreal USA | 2 | Marketed |
| Mar 31, 2008 | Anthelios 40NDA 22009 · New formulation or manufacturer | Loreal USA | 4 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
